Met Life Investment Management, LLC Aquestive Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 36,096 shares of AQST stock, worth $131,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,096
Previous 19,380
86.25%
Holding current value
$131,750
Previous $50,000
258.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
122Shares Held
46.8MCall Options Held
517KPut Options Held
207K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$35.8 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$20.3 Million2.87% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$19.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.26MShares$15.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.77MShares$10.1 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $195M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...